Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
67 participants
INTERVENTIONAL
2023-10-01
2024-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
New Diagnosed Type 2 Diabetes - Online Education
NCT05341063
Investigation of the Effect of Web-based Education on Self-Care Management and Family Support in Women With Type 2 Diabetes
NCT05266742
Online Diabetic Foot Support Program- Care Kit
NCT06760416
The Effect of Web-Based Education in Patients With Type 2 Diabetes
NCT04626531
Tele Nursing Application For Type 1 Diabetes Mellitus Adolescents
NCT05211479
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Group
intervention+ Follow-up at 0-3-6 months
online support programe
Individuals in the experimental group received online training and were subsequently provided with continuous follow-up, counseling, motivation and informative message support for three months. In addition, patients were given a target board containing a daily diabetes management program and were asked to use it for three months.
Control Group
Follow-up at 0-3-6 months
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
online support programe
Individuals in the experimental group received online training and were subsequently provided with continuous follow-up, counseling, motivation and informative message support for three months. In addition, patients were given a target board containing a daily diabetes management program and were asked to use it for three months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to communicate in Turkish,
* diagnosed with type 2 diabetes,
* newly started insulin treatment,
* having and using information technology products (telephone, computer)
* willing to participate in the study voluntarily were included in the study.
* those who do not agree to participate in the study were not included.
Exclusion Criteria
* auditory or cognitive impairments,
* a condition that prevents communication,
* cannot use information technology products,
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Scientific and Technological Research Council of Turkey
OTHER
Dilek Büyükkaya Besen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dilek Büyükkaya Besen
Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dilek D Büyükkaya Besen, PhD
Role: PRINCIPAL_INVESTIGATOR
Dokuz Eylul University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dokuz Eylül University
Izmir, Alsancak, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DokuzEU-IHH-DBB-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.